“An experimental drug combination cured 70 percent of patients with hepatitis C in early trials, offering hope of a simpler remedy for the chronic liver disease, US researchers said Tuesday. The phase II trial described in the Journal of the American Medical Association (JAMA) studied the effectiveness and safety of an experimental drug, sofosbuvir, taken with the licensed antiviral drug ribavirin. The drugs were administered orally, an improvement over the current treatment which involves weekly injections with interferon-alpha and can cause depression, flu-like symptoms and anemia. All nine who completed the regimen had no virus detectable 24 weeks after therapy ended.”
Related posts:
Feds Float Trial Balloon; 'Consider' Targeting American In Drone Strike
China February exports tumble unexpectedly
American Express Ex-Chief Privacy Officer On 'The Last Days of Cash'
France Proposes an Internet Tax
Winklevoss twins say Bitcoin could become a country's currency
How can you buy illegal drugs online?
Swiss Offshore-Adviser's Guilty Plea Marks a Shift in Tax Crackdown
Estonia's plan to let anyone become European – digitally
Insider buying of gold stocks surges to multi-year highs
Feds subjected New Mexico woman to vaginal, anal drug search
Police secretly track cellphones to solve routine crimes
Shell cuts 6,500 jobs as oil price slump continues
Two-thirds of millionaires left Britain to avoid 50p tax rate
Woman, clinically dead for 42-minutes, brought back to life by Australian doctors
How a 1983 US-NATO war game came close to provoking nuclear attack